Research Paper Volume 16, Issue 12 pp 10252—10270
Characterization of tumor endothelial cells (TEC) in gastric cancer and development of a TEC-based risk signature using single-cell RNA-seq and bulk RNA-seq data
Figure 10. The response of risk score to immune checkpoint inhibitors in IMvigor210 cohort and GSE78220 cohort. (A) Prognostic differences among risk score groups in the IMvigor210 cohort. (B) Differences in risk scores among immunotherapy responses in the IMvigor210 cohort. (C) Distribution of immunotherapy responses among risk score groups in the IMvigor210 cohort. (D) Prognostic differences between risk score groups in early-stage patients in the IMvigor210 cohort. (E) Prognostic differences between risk score groups in advanced patients in the IMvigor210 cohort. (F) Prognostic differences in risk score groups in the GSE78220 cohort. (G) Differences in risk scores among immunotherapy responses in the IMvigor210 cohort. (H) Distribution of immunotherapy responses among risk score groups in the GSE78220 cohort. *P < 0.05, ***P < 0.001.